Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ureteral Calculi: early-phase trial registry
1 of 5 indexed Ureteral Calculi trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Ureteral Calculi: 5 US clinical trials tracked, 1 recruiting.
Ureteral Calculi is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Watson Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition ureteral-calculi
OPEN 1 | RECR 20% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Ureteral Calculi lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ureteral Calculi on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ureteral Calculi is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Ureteral Calculi research.
Watson Pharmaceuticals accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Ureteral Calculi trials plan to enrol fewer than 100 people.
Median target enrolment is 74 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Ureteral Calculi research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
Northwestern University
NCT05100017
Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)
University of Washington
NCT03873259
Study of Silodosin to Facilitate Passage of Urinary Stones
Watson Pharmaceuticals
NCT01144949
The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic
Washington University School of Medicine
NCT02577146
Standard vs Mini-PCNL for the Treatment of Stone Disease
The Cleveland Clinic
NCT04069013
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Ureteral Calculi records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ureteral Calculi trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ureteral Calculi page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Ureteral Calculi trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Watson Pharmaceuticals sponsors the most Ureteral Calculi trials on record, review their full trial history before evaluating a specific study. See Watson Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ureteral Calculi condition card totals 5 registered trials; most-linked intervention renal and bladder ultrasound with ureteral jet assessment; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.